Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS-CoV-2 and influenza A

Research output: Contribution to journalArticlepeer-review

Abstract

Reactive infectious mucocutaneous eruption (RIME) was proposed as new terminology to encompass postinfectious mucocutaneous eruptions. The term includes all postinfectious mucocutaneous eruptions such as the widely reported Mycoplasma pneumoniae-induced rash and mucositis (MIRM). Very few reports in the literature regarding recurrent RIME are found. We present two adolescent cases of recurrent RIME that involve SARS-CoV-2 and influenza A where the latter is a newly reported infectious trigger; in both patients, the initial episode was likely triggered by Mycoplasma pneumoniae (MP) infection.

Original languageEnglish (US)
Pages (from-to)1222-1225
Number of pages4
JournalPediatric Dermatology
Volume38
Issue number5
Early online dateSep 13 2021
DOIs
StatePublished - Sep 2021

Bibliographical note

Publisher Copyright:
© 2021 Wiley Periodicals LLC.

Keywords

  • Mycoplasma infection
  • Mycoplasma-induced rash and mucositis
  • mucositis
  • reactive infectious mucocutaneous eruption

PubMed: MeSH publication types

  • Case Reports

Fingerprint

Dive into the research topics of 'Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS-CoV-2 and influenza A'. Together they form a unique fingerprint.

Cite this